Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Minocycline | hsa00020 | Citrate cycle (TCA cycle) | 3.41E-02 | 2 | P50213, O14521 | IDH3A, SDHD | More | | Minocycline | hsa00051 | Fructose and mannose metabolism | 3.92E-03 | 3 | P15121, P19367, P08237 | AKR1B1, HK1, PFKM | More | | Minocycline | hsa00052 | Galactose metabolism | 3.77E-04 | 5 | P06280, P08237, O43451, P15121, P19367 | GLA, PFKM, MGAM, AKR1B1, HK1 | More | | Minocycline | hsa00190 | Oxidative phosphorylation | 4.36E-03 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Minocycline | hsa00220 | Arginine biosynthesis | 2.33E-02 | 2 | P05089, P49448 | ARG1, GLUD2 | More | | Minocycline | hsa00500 | Starch and sucrose metabolism | 1.91E-04 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | | Minocycline | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Minocycline | hsa00564 | Glycerophospholipid metabolism | 3.56E-02 | 3 | P48651, Q9Y6K0, P35790 | PTDSS1, CEPT1, CHKA | More | | Minocycline | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Minocycline | hsa00591 | Linoleic acid metabolism | 4.07E-02 | 1 | P11712 | CYP2C9 | More | | Minocycline | hsa00600 | Sphingolipid metabolism | 4.50E-02 | 1 | P15289 | ARSA | More | | Minocycline | hsa00730 | Thiamine metabolism | 1.55E-03 | 2 | P05186, P24666 | ALPL, ACP1 | More | | Minocycline | hsa00920 | Sulfur metabolism | 3.18E-02 | 1 | Q16762 | TST | More | | Minocycline | hsa00970 | Aminoacyl-tRNA biosynthesis | 3.78E-02 | 2 | O95363, Q15046 | FARS2, KARS | More | | Minocycline | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Minocycline | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Minocycline | hsa01100 | Metabolic pathways | 2.92E-03 | 39 | Q9NR34, Q9Y234, P35790, P05089, Q16772, P30041, P19367, P48426, P22557, P32320, P20839, P22748, P55809, P06280, Q16875, O43286, O43451, Q9Y6K0, P05186, P24666, P15121, P08237, O95861, Q9HCC0, P33121, Q86VZ5, P48651, P57054, Q9UNP4, Q9BX95, P32321, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P06737, Q969G6, P14927 | MAN1C1, LIPT1, CHKA, ARG1, GSTA3, PRDX6, HK1, PIP4K2A, ALAS2, CDA, IMPDH1, CA4, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, CEPT1, ALPL, ACP1, AKR1B1, PFKM, BPNT1, MCCC2, ACSL1, SGMS1, PTDSS1, PIGP, ST3GAL5, SGPP1, DCTD, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, PYGL, RFK, UQCRB | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9NR34 | MAN1C1 | Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC | -0.716 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | Q9Y234 | LIPT1 | Lipoyltransferase 1, mitochondrial | 0.829 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P35790 | CHKA | Choline kinase alpha | -0.778 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05089 | ARG1 | Arginase-1 | 0.702 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | Q16772 | GSTA3 | Glutathione S-transferase A3 | -0.791 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P30041 | PRDX6 | Peroxiredoxin-6 | 0.893 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P19367 | HK1 | Hexokinase-1 | 0.777 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P48426 | PIP4K2A | Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | 0.745 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P22557 | ALAS2 | 5-aminolevulinate synthase, erythroid-specific, mitochondrial | 0.707 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32320 | CDA | Cytidine deaminase | 0.701 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | 0.828 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P22748 | CA4 | Carbonic anhydrase 4 | 0.767 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P55809 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial | -0.746 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06280 | GLA | Alpha-galactosidase A | 0.714 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.849 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.917 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43451 | MGAM | Maltase-glucoamylase | 0.871 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | Q9Y6K0 | CEPT1 | Choline/ethanolaminephosphotransferase 1 | 0.802 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | 0.901 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | -0.832 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P15121 | AKR1B1 | Aldo-keto reductase family 1 member B1 | 0.732 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P08237 | PFKM | ATP-dependent 6-phosphofructokinase, muscle type | 0.82 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | O95861 | BPNT1 | 3'(2'),5'-bisphosphate nucleotidase 1 | -0.702 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9HCC0 | MCCC2 | Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial | -0.782 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 0.886 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.795 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P48651 | PTDSS1 | Phosphatidylserine synthase 1 | 0.802 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P57054 | PIGP | Phosphatidylinositol N-acetylglucosaminyltransferase subunit P | -0.881 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.819 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.743 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32321 | DCTD | Deoxycytidylate deaminase | -0.748 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O75911 | DHRS3 | Short-chain dehydrogenase/reductase 3 | -0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | -0.737 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.883 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P46976 | GYG1 | Glycogenin-1 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06737 | PYGL | Glycogen phosphorylase, liver form | 0.863 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | Q969G6 | RFK | Riboflavin kinase | 0.797 | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | P14927 | UQCRB | Cytochrome b-c1 complex subunit 7 | 0.721 |
| Minocycline | hsa01230 | Biosynthesis of amino acids | 3.91E-02 | 3 | P51854, Q99707, P50213 | TKTL1, MTR, IDH3A | More | | Minocycline | hsa01240 | Biosynthesis of cofactors | 4.63E-02 | 3 | Q969G6, P22557, Q9Y234 | RFK, ALAS2, LIPT1 | More | | Minocycline | hsa01522 | Endocrine resistance | 4.55E-02 | 5 | P14780, P22694, Q9UM47, P10415, Q13323 | MMP9, PRKACB, NOTCH3, BCL2, BIK | More | | Minocycline | hsa01523 | Antifolate resistance | 1.68E-02 | 2 | Q92820, P04818 | GGH, TYMS | More | | Minocycline | hsa01524 | Platinum drug resistance | 1.79E-02 | 2 | O15392, P11388 | BIRC5, TOP2A | More | | Minocycline | hsa03010 | Ribosome | 1.88E-02 | 6 | P62753, P25398, P32969, P62829, P18077, P36578 | RPS6, RPS12, RPL9, RPL23, RPL35A, RPL4 | More | | Minocycline | hsa03013 | RNA transport | 4.49E-02 | 5 | P62826, Q9UBU9, P63279, P68104, Q14232 | RAN, NXF1, UBE2I, EEF1A1, EIF2B1 | More | | Minocycline | hsa03018 | RNA degradation | 5.00E-02 | 1 | Q9NQT4 | EXOSC5 | More | | Minocycline | hsa03020 | RNA polymerase | 6.08E-05 | 4 | P30876, P24928, P62487, Q9Y535 | POLR2B, POLR2A, POLR2G, POLR3H | More | | Minocycline | hsa03040 | Spliceosome | 1.28E-05 | 13 | O43143, O60508, P08579, P26368, Q13595, Q07955, Q01130, P84103, Q13243, P11142, Q9Y2W2, O43447, O75643 | DHX15, CDC40, SNRPB2, U2AF2, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, HSPA8, WBP11, PPIH, ASCC3L1 | More | | Minocycline | hsa03060 | Protein export | 3.56E-02 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Minocycline | hsa04012 | ErbB signaling pathway | 3.15E-02 | 3 | P16333, P19174, P01106 | NCK1, PLCG1, MYC | More | | Minocycline | hsa04014 | Ras signaling pathway | 2.36E-02 | 8 | P42338, P20827, P49767, Q13009, Q7LDG7, P63218, P50151, P19174 | PIK3CB, EFNA1, VEGFC, TIAM1, RASGRP2, GNG5, GNG10, PLCG1 | More | | Minocycline | hsa04015 | Rap1 signaling pathway | 3.98E-04 | 14 | P09603, P20827, P49767, Q9GZP0, Q96FS4, P11215, P25116, Q8TEU7, Q13009, Q7LDG7, P42338, P08514, Q86WV1, P19174 | CSF1, EFNA1, VEGFC, PDGFD, SIPA1, ITGAM, F2R, RAPGEF6, TIAM1, RASGRP2, PIK3CB, ITGA2B, SKAP1, PLCG1 | More | | Minocycline | hsa04020 | Calcium signaling pathway | 1.09E-03 | 7 | Q08828, Q13557, P61073, P0DP24, P0DP23, P05141, P51828 | ADCY1, CAMK2D, CXCR4, CALM2, CALM1, SLC25A5, ADCY7 | More | | Minocycline | hsa04022 | cGMP-PKG signaling pathway | 2.77E-04 | 8 | Q99941, P18848, P31751, Q08828, P51828, P05141, P0DP24, P0DP23 | CREBL1, ATF4, AKT2, ADCY1, ADCY7, SLC25A5, CALM2, CALM1 | More | | Minocycline | hsa04024 | cAMP signaling pathway | 3.94E-02 | 4 | Q08828, P51828, P31751, P0DP23 | ADCY1, ADCY7, AKT2, CALM1 | More | | Minocycline | hsa04060 | Cytokine-cytokine receptor interaction | 8.61E-03 | 9 | P14784, P27930, P14778, Q13651, Q9HBE5, P25024, Q9UBD3, P47992, Q93038 | IL2RB, IL1R2, IL1R1, IL10RA, IL21R, CXCR1, XCL2, XCL1, TNFRSF25 | More | | Minocycline | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 1.32E-04 | 7 | Q8NHW4, P25024, P61073, P47992, Q9UBD3, Q13651, P14784 | CCL4L2, CXCR1, CXCR4, XCL1, XCL2, IL10RA, IL2RB | More | | Minocycline | hsa04062 | Chemokine signaling pathway | 1.70E-04 | 14 | P25024, P47992, Q9UBD3, P09769, P07948, P42338, P19174, P63218, P50151, P43250, P49407, Q7LDG7, Q13009, Q8WYR1 | CXCR1, XCL1, XCL2, FGR, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6, ARRB1, RASGRP2, TIAM1, PIK3R5 | More | | Minocycline | hsa04064 | NF-kappa B signaling pathway | 6.30E-07 | 17 | P10415, Q13489, P51617, O00463, P14778, P01584, P01375, Q04759, Q9UDY8, Q13077, Q16548, Q8WV28, P63279, P24522, Q8NHW4, P09341, Q9NQC7 | BCL2, BIRC3, IRAK1, TRAF5, IL1R1, IL1B, TNF, PRKCQ, MALT1, TRAF1, BCL2A1, BLNK, UBE2I, GADD45A, CCL4L2, CXCL1, CYLD | More | | Minocycline | hsa04070 | Phosphatidylinositol signaling system | 9.86E-03 | 4 | P0DP23, O14986, Q16760, P48426 | CALM1, PIP5K1B, DGKD, PIP4K2A | More | | Minocycline | hsa04071 | Sphingolipid signaling pathway | 4.78E-05 | 8 | P17252, P21453, Q9H228, P01375, Q13362, Q9BX95, Q16539, P10415 | PRKCA, S1PR1, EDG8, TNF, PPP2R5C, SGPP1, MAPK14, BCL2 | More | | Minocycline | hsa04072 | Phospholipase D signaling pathway | 2.40E-03 | 6 | P31751, O14986, Q15438, Q08828, P51828, Q16760 | AKT2, PIP5K1B, PSCD1, ADCY1, ADCY7, DGKD | More | | Minocycline | hsa04080 | Neuroactive ligand-receptor interaction | 4.72E-02 | 8 | P08311, Q15722, P21453, Q9H228, O00398, P21462, P21730, Q16581 | CTSG, LTB4R, S1PR1, EDG8, P2RY10, FPR1, C5AR1, C3AR1 | More | | Minocycline | hsa04110 | Cell cycle | 6.63E-04 | 6 | P06493, O60566, P30304, P33981, P42773, P01106 | CDK1, BUB1B, CDC25A, TTK, CDKN2C, MYC | More | | Minocycline | hsa04114 | Oocyte meiosis | 1.78E-03 | 8 | Q13557, P0DP24, P0DP23, Q08828, P51828, P27348, Q13362, Q14738 | CAMK2D, CALM2, CALM1, ADCY1, ADCY7, YWHAQ, PPP2R5C, PPP2R5D | More | | Minocycline | hsa04120 | Ubiquitin mediated proteolysis | 1.68E-02 | 2 | O00762, Q14139 | UBE2C, UBE4A | More | | Minocycline | hsa04122 | Sulfur relay system | 3.18E-02 | 1 | Q16762 | TST | More | | Minocycline | hsa04140 | Autophagy - animal | 7.25E-04 | 10 | P31751, Q7L523, O75460, P22694, Q14643, P10415, Q9H1Y0, Q04759, Q96GC9, Q8TEV9 | AKT2, RRAGA, ERN1, PRKACB, ITPR1, BCL2, ATG5, PRKCQ, TMEM49, SMCR8 | More | | Minocycline | hsa04141 | Protein processing in endoplasmic reticulum | 4.88E-02 | 4 | P18848, O60337, P11142, P07900 | ATF4, MARH6, HSPA8, HSP90AA1 | More | | Minocycline | hsa04145 | Phagosome | 1.08E-02 | 8 | O75015, Q15080, P14598, Q13509, P05164, O60603, P35443, P13765 | FCGR3B, NCF4, NCF1, TUBB3, MPO, TLR2, THBS4, HLA-DOB | More | | Minocycline | hsa04151 | PI3K-Akt signaling pathway | 1.92E-03 | 16 | P42338, P43657, P01106, P09603, P20827, P49767, Q9GZP0, P08238, Q8WYR1, P63218, P50151, P13612, O15335, Q13751, P14784, P30281 | PIK3CB, P2RY5, MYC, CSF1, EFNA1, VEGFC, PDGFD, HSP90AB1, PIK3R5, GNG5, GNG10, ITGA4, CHAD, LAMB3, IL2RB, CCND3 | More | | Minocycline | hsa04211 | Longevity regulating pathway | 2.57E-03 | 5 | P31751, Q08828, P51828, Q99941, P18848 | AKT2, ADCY1, ADCY7, CREBL1, ATF4 | More | | Minocycline | hsa04213 | Longevity regulating pathway - multiple species | 4.54E-02 | 3 | P31751, Q08828, P51828 | AKT2, ADCY1, ADCY7 | More | | Minocycline | hsa04217 | Necroptosis | 1.54E-05 | 9 | P23458, Q9NQC7, P07900, P15104, P05141, P01584, P0C0S5, Q13557, Q9H444 | JAK1, CYLD, HSP90AA1, GLUL, SLC25A5, IL1B, H2AFZ, CAMK2D, CHMP4B | More | | Minocycline | hsa04261 | Adrenergic signaling in cardiomyocytes | 3.19E-05 | 10 | Q08828, P51828, P31751, Q99941, P18848, Q13362, Q14738, P0DP24, P0DP23, Q13557 | ADCY1, ADCY7, AKT2, CREBL1, ATF4, PPP2R5C, PPP2R5D, CALM2, CALM1, CAMK2D | More | | Minocycline | hsa04340 | Hedgehog signaling pathway | 3.46E-02 | 4 | P49841, P22694, Q13635, P10415 | GSK3B, PRKACB, PTCH1, BCL2 | More | | Minocycline | hsa04360 | Axon guidance | 4.04E-02 | 6 | P16333, P20827, O95631, P42338, P07332, P19174 | NCK1, EFNA1, NTN1, PIK3CB, FES, PLCG1 | More | | Minocycline | hsa04371 | Apelin signaling pathway | 1.11E-03 | 11 | P63218, P50151, Q8WYR1, P31751, Q08828, P51828, Q14814, Q14344, Q13485, P84022, P0DP23 | GNG5, GNG10, PIK3R5, AKT2, ADCY1, ADCY7, MEF2D, GNA13, SMAD4, SMAD3, CALM1 | More | | Minocycline | hsa04380 | Osteoclast differentiation | 9.07E-05 | 10 | Q9NQC7, Q9UQC2, Q16539, P23458, P31751, P01584, P14778, O75015, P01375, Q8N149 | CYLD, GAB2, MAPK14, JAK1, AKT2, IL1B, IL1R1, FCGR3B, TNF, LILRA2 | More | | Minocycline | hsa04512 | ECM-receptor interaction | 3.73E-02 | 2 | P07359, P08514 | GP1BA, ITGA2B | More | | Minocycline | hsa04514 | Cell adhesion molecules | 8.19E-03 | 3 | P16109, P56750, O00501 | SELP, CLDN17, CLDN5 | More | | Minocycline | hsa04530 | Tight junction | 2.47E-05 | 5 | Q8TEU7, P16989, P56750, O00501, Q14247 | RAPGEF6, CSDA, CLDN17, CLDN5, CTTN | More | | Minocycline | hsa04610 | Complement and coagulation cascades | 6.18E-03 | 3 | P25116, P09871, P0C0L4 | F2R, C1S, C4A | More | | Minocycline | hsa04611 | Platelet activation | 5.18E-05 | 5 | P25116, P08514, Q15746, Q8WYR1, P07359 | F2R, ITGA2B, MYLK, PIK3R5, GP1BA | More | | Minocycline | hsa04612 | Antigen processing and presentation | 1.94E-03 | 8 | P13765, P48382, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | | Minocycline | hsa04613 | Neutrophil extracellular trap formation | 3.09E-06 | 23 | P17252, P16109, O60603, P05164, P08246, Q9UM07, Q6FI13, Q93077, P62807, O60814, P68431, P14598, Q15080, P20160, P08311, P49913, O75015, P21730, P08514, P21462, P07359, O43315, Q16539 | PRKCA, SELP, TLR2, MPO, ELA2, PADI4, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, AZU1, CTSG, CAMP, FCGR3B, C5AR1, ITGA2B, FPR1, GP1BA, AQP9, MAPK14 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P22894 | MMP8 | Neutrophil collagenase | P17252 | PRKCA | Protein kinase C alpha type | -0.759 | P18054 | ALOX12 | Polyunsaturated fatty acid lipoxygenase ALOX12 | P16109 | SELP | P-selectin | 0.819 | P14780 | MMP9 | Matrix metalloproteinase-9 | O60603 | TLR2 | Toll-like receptor 2 | 0.89 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | O60603 | TLR2 | Toll-like receptor 2 | 0.772 | P22894 | MMP8 | Neutrophil collagenase | O60603 | TLR2 | Toll-like receptor 2 | 0.89 | P14780 | MMP9 | Matrix metalloproteinase-9 | P05164 | MPO | Myeloperoxidase | 0.812 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P05164 | MPO | Myeloperoxidase | 0.909 | P22894 | MMP8 | Neutrophil collagenase | P05164 | MPO | Myeloperoxidase | 0.905 | P14780 | MMP9 | Matrix metalloproteinase-9 | P08246 | ELA2 | Neutrophil elastase | 0.859 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P08246 | ELA2 | Neutrophil elastase | 0.889 | P22894 | MMP8 | Neutrophil collagenase | P08246 | ELA2 | Neutrophil elastase | 0.985 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.9 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 1 | P22894 | MMP8 | Neutrophil collagenase | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.877 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.74 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.707 | P22894 | MMP8 | Neutrophil collagenase | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | 0.909 | P11712 | CYP2C9 | Cytochrome P450 2C9 | Q93077 | HIST1H2AC | Histone H2A type 1-C | 0.754 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | P11712 | CYP2C9 | Cytochrome P450 2C9 | O60814 | H2BC12 | Histone H2B type 1-K | 0.728 | P18054 | ALOX12 | Polyunsaturated fatty acid lipoxygenase ALOX12 | O60814 | H2BC12 | Histone H2B type 1-K | 0.783 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.845 | P22894 | MMP8 | Neutrophil collagenase | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.74 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.869 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.795 | P22894 | MMP8 | Neutrophil collagenase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.963 | P14780 | MMP9 | Matrix metalloproteinase-9 | P20160 | AZU1 | Azurocidin | 0.734 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P20160 | AZU1 | Azurocidin | 0.884 | P22894 | MMP8 | Neutrophil collagenase | P20160 | AZU1 | Azurocidin | 0.824 | P14780 | MMP9 | Matrix metalloproteinase-9 | P08311 | CTSG | Cathepsin G | 0.79 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P08311 | CTSG | Cathepsin G | 0.884 | P22894 | MMP8 | Neutrophil collagenase | P08311 | CTSG | Cathepsin G | 0.8 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P49913 | CAMP | Cathelicidin antimicrobial peptide | 0.737 | P22894 | MMP8 | Neutrophil collagenase | P49913 | CAMP | Cathelicidin antimicrobial peptide | 0.7 | P14780 | MMP9 | Matrix metalloproteinase-9 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.928 | P22894 | MMP8 | Neutrophil collagenase | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.734 | P14780 | MMP9 | Matrix metalloproteinase-9 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.942 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.825 | P22894 | MMP8 | Neutrophil collagenase | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.756 | P18054 | ALOX12 | Polyunsaturated fatty acid lipoxygenase ALOX12 | P08514 | ITGA2B | Integrin alpha-IIb | 0.941 | P14780 | MMP9 | Matrix metalloproteinase-9 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.912 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.733 | P22894 | MMP8 | Neutrophil collagenase | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.88 | P18054 | ALOX12 | Polyunsaturated fatty acid lipoxygenase ALOX12 | P07359 | GP1BA | Platelet glycoprotein Ib alpha chain | 0.876 | P14780 | MMP9 | Matrix metalloproteinase-9 | O43315 | AQP9 | Aquaporin-9 | 0.837 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 |
| Minocycline | hsa04620 | Toll-like receptor signaling pathway | 2.54E-03 | 3 | P01584, P31751, Q8NHW4 | IL1B, AKT2, CCL4L2 | More | | Minocycline | hsa04621 | NOD-like receptor signaling pathway | 2.62E-02 | 11 | Q16539, Q14643, P10599, Q9H1Y0, P43490, O00463, P10415, Q05823, P01375, P09341, P12838 | MAPK14, ITPR1, TXN, ATG5, PBEF1, TRAF5, BCL2, RNASEL, TNF, CXCL1, DEFA4 | More | | Minocycline | hsa04623 | Cytosolic DNA-sensing pathway | 7.66E-06 | 3 | P01584, Q9Y535, Q8NHW4 | IL1B, POLR3H, CCL4L2 | More | | Minocycline | hsa04625 | C-type lectin receptor signaling pathway | 1.14E-03 | 8 | Q9ULY5, P01584, Q9NQC7, P20749, P01375, P31751, P0DP23, Q16539 | CLEC4E, IL1B, CYLD, BCL3, TNF, AKT2, CALM1, MAPK14 | More | | Minocycline | hsa04630 | JAK-STAT signaling pathway | 4.54E-02 | 3 | P31751, P23458, Q13651 | AKT2, JAK1, IL10RA | More | | Minocycline | hsa04640 | Hematopoietic cell lineage | 5.54E-05 | 15 | P13612, P14778, P27930, P11215, P15144, P25063, P07766, P09693, P01732, P01730, P06127, P09564, P13765, P01375, P09603 | ITGA4, IL1R1, IL1R2, ITGAM, ANPEP, CD24, CD3E, CD3G, CD8A, CD4, CD5, CD7, HLA-DOB, TNF, CSF1 | More | | Minocycline | hsa04657 | IL-17 signaling pathway | 2.20E-05 | 9 | P07900, O00463, Q16539, P49841, P09341, P14780, P80188, P01375, P01584 | HSP90AA1, TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF, IL1B | More | | Minocycline | hsa04658 | Th1 and Th2 cell differentiation | 6.36E-08 | 13 | Q04759, P07766, P20963, P09693, Q16539, P19174, P06239, Q14765, P23771, Q9UL17, P14784, P13765, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, LCK, STAT4, GATA3, TBX21, IL2RB, HLA-DOB, RUNX3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P14780 | MMP9 | Matrix metalloproteinase-9 | Q04759 | PRKCQ | Protein kinase C theta type | -0.787 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q04759 | PRKCQ | Protein kinase C theta type | -0.91 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | Q04759 | PRKCQ | Protein kinase C theta type | 0.79 | P43250 | GRK6 | G protein-coupled receptor kinase 6 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.767 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.855 | P14780 | MMP9 | Matrix metalloproteinase-9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.745 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.828 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.895 | P14780 | MMP9 | Matrix metalloproteinase-9 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.719 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.793 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | P43250 | GRK6 | G protein-coupled receptor kinase 6 | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.787 | P43250 | GRK6 | G protein-coupled receptor kinase 6 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.702 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.867 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.861 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.815 | P14780 | MMP9 | Matrix metalloproteinase-9 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.747 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.905 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.808 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.788 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.79 | P43250 | GRK6 | G protein-coupled receptor kinase 6 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.701 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.753 | P14780 | MMP9 | Matrix metalloproteinase-9 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.714 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.757 | P43250 | GRK6 | G protein-coupled receptor kinase 6 | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.828 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.82 |
| Minocycline | hsa04659 | Th17 cell differentiation | 2.93E-05 | 12 | Q04759, P19174, P06239, P14784, P14778, Q9HBE5, Q9UL17, P84022, Q13485, P08238, P07766, P20963 | PRKCQ, PLCG1, LCK, IL2RB, IL1R1, IL21R, TBX21, SMAD3, SMAD4, HSP90AB1, CD3E, CD247 | More | | Minocycline | hsa04660 | T cell receptor signaling pathway | 7.97E-07 | 15 | P01375, Q9UDY8, Q04759, P42338, P10747, O95267, Q08881, P07766, P20963, P09693, P01732, Q13191, P06239, Q16539, P49841 | TNF, MALT1, PRKCQ, PIK3CB, CD28, RASGRP1, ITK, CD3E, CD247, CD3G, CD8A, CBLB, LCK, MAPK14, GSK3B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P14780 | MMP9 | Matrix metalloproteinase-9 | P01375 | TNF | Tumor necrosis factor | 0.897 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P01375 | TNF | Tumor necrosis factor | 0.788 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.767 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | -0.779 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q04759 | PRKCQ | Protein kinase C theta type | -0.787 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q04759 | PRKCQ | Protein kinase C theta type | -0.91 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | Q04759 | PRKCQ | Protein kinase C theta type | 0.79 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.791 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P10747 | CD28 | T-cell-specific surface glycoprotein CD28 | -0.735 | P14780 | MMP9 | Matrix metalloproteinase-9 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.792 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.799 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.855 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.855 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.855 | P14780 | MMP9 | Matrix metalloproteinase-9 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.745 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.828 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.895 | P14780 | MMP9 | Matrix metalloproteinase-9 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.719 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.793 | P14780 | MMP9 | Matrix metalloproteinase-9 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.742 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.839 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.744 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.793 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.796 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.738 | Q15131 | CDK10 | Cyclin-dependent kinase 10 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.867 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.778 | P14780 | MMP9 | Matrix metalloproteinase-9 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.75 |
| Minocycline | hsa04662 | B cell receptor signaling pathway | 2.31E-04 | 5 | P42338, P60033, P07948, P21854, Q8N149 | PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Minocycline | hsa04664 | Fc epsilon RI signaling pathway | 2.06E-04 | 7 | P01375, Q16539, P42338, Q9UQC2, P07948, P19174, P09917 | TNF, MAPK14, PIK3CB, GAB2, LYN, PLCG1, ALOX5 | More | | Minocycline | hsa04666 | Fc gamma R-mediated phagocytosis | 3.08E-02 | 5 | O75015, P06396, O14494, P14598, P17252 | FCGR3B, GSN, PLPP1, NCF1, PRKCA | More | | Minocycline | hsa04668 | TNF signaling pathway | 2.21E-02 | 5 | P01375, O00463, Q16539, P20749, P14780 | TNF, TRAF5, MAPK14, BCL3, MMP9 | More | | Minocycline | hsa04672 | Intestinal immune network for IgA production | 1.66E-02 | 3 | P10747, P13765, P13612 | CD28, HLA-DOB, ITGA4 | More | | Minocycline | hsa04713 | Circadian entrainment | 2.10E-03 | 5 | P0DP24, P0DP23, Q13557, Q08828, P51828 | CALM2, CALM1, CAMK2D, ADCY1, ADCY7 | More | | Minocycline | hsa04720 | Long-term potentiation | 2.10E-03 | 5 | Q13557, P0DP24, P0DP23, P18848, Q08828 | CAMK2D, CALM2, CALM1, ATF4, ADCY1 | More | | Minocycline | hsa04721 | Synaptic vesicle cycle | 1.80E-02 | 2 | Q13488, P31645 | TCIRG1, SLC6A4 | More | | Minocycline | hsa04725 | Cholinergic synapse | 1.44E-03 | 5 | Q08828, P51828, P18848, Q13557, P31751 | ADCY1, ADCY7, ATF4, CAMK2D, AKT2 | More | | Minocycline | hsa04728 | Dopaminergic synapse | 6.42E-04 | 9 | P31751, Q99941, P18848, Q13557, Q13362, Q14738, P0DP24, P0DP23, O15516 | AKT2, CREBL1, ATF4, CAMK2D, PPP2R5C, PPP2R5D, CALM2, CALM1, CLOCK | More | | Minocycline | hsa04750 | Inflammatory mediator regulation of TRP channels | 6.39E-06 | 10 | P14778, P01584, Q08828, P51828, Q13557, P42338, P24723, Q04759, P0DP24, P0DP23 | IL1R1, IL1B, ADCY1, ADCY7, CAMK2D, PIK3CB, PRKCH, PRKCQ, CALM2, CALM1 | More | | Minocycline | hsa04810 | Regulation of actin cytoskeleton | 2.58E-02 | 3 | Q15746, P08514, P25116 | MYLK, ITGA2B, F2R | More | | Minocycline | hsa04911 | Insulin secretion | 5.02E-05 | 5 | Q08828, P51828, Q99941, P18848, Q13557 | ADCY1, ADCY7, CREBL1, ATF4, CAMK2D | More | | Minocycline | hsa04912 | GnRH signaling pathway | 2.59E-04 | 6 | Q08828, P51828, P18848, Q13557, P0DP24, P0DP23 | ADCY1, ADCY7, ATF4, CAMK2D, CALM2, CALM1 | More | | Minocycline | hsa04915 | Estrogen signaling pathway | 2.13E-02 | 5 | P18848, Q08828, P51828, P31751, P0DP23 | ATF4, ADCY1, ADCY7, AKT2, CALM1 | More | | Minocycline | hsa04916 | Melanogenesis | 4.36E-04 | 5 | Q13557, P0DP24, P0DP23, Q08828, P51828 | CAMK2D, CALM2, CALM1, ADCY1, ADCY7 | More | | Minocycline | hsa04918 | Thyroid hormone synthesis | 4.47E-03 | 5 | Q08828, P51828, Q99941, P18848, P02768 | ADCY1, ADCY7, CREBL1, ATF4, ALB | More | | Minocycline | hsa04923 | Regulation of lipolysis in adipocytes | 5.15E-03 | 3 | Q08828, P51828, P31751 | ADCY1, ADCY7, AKT2 | More | | Minocycline | hsa04924 | Renin secretion | 3.64E-02 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | | Minocycline | hsa04925 | Aldosterone synthesis and secretion | 1.54E-05 | 7 | Q99941, P18848, Q08828, P51828, P0DP24, P0DP23, Q13557 | CREBL1, ATF4, ADCY1, ADCY7, CALM2, CALM1, CAMK2D | More | | Minocycline | hsa04926 | Relaxin signaling pathway | 2.46E-02 | 4 | P31751, P18848, Q08828, P51828 | AKT2, ATF4, ADCY1, ADCY7 | More | | Minocycline | hsa04927 | Cortisol synthesis and secretion | 1.43E-05 | 6 | Q14643, Q99941, P18848, Q08828, P51828, P22694 | ITPR1, CREBL1, ATF4, ADCY1, ADCY7, PRKACB | More | | Minocycline | hsa04928 | Parathyroid hormone synthesis, secretion and action | 3.77E-02 | 4 | Q08828, P51828, Q99941, P18848 | ADCY1, ADCY7, CREBL1, ATF4 | More | | Minocycline | hsa04932 | Non-alcoholic fatty liver disease | 4.14E-05 | 8 | P31751, P18848, O75460, P01584, P13073, P12074, O15239, O95298 | AKT2, ATF4, ERN1, IL1B, COX4I1, COX6A1, NDUFA1, NDUFC2 | More | | Minocycline | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 3.21E-02 | 5 | P84022, Q13485, P42338, P49767, P19174 | SMAD3, SMAD4, PIK3CB, VEGFC, PLCG1 | More | | Minocycline | hsa04934 | Cushing syndrome | 4.71E-05 | 6 | Q99941, P18848, Q08828, P51828, O15169, Q13557 | CREBL1, ATF4, ADCY1, ADCY7, AXIN1, CAMK2D | More | | Minocycline | hsa04935 | Growth hormone synthesis, secretion and action | 2.57E-03 | 5 | Q08828, P51828, Q99941, P18848, P31751 | ADCY1, ADCY7, CREBL1, ATF4, AKT2 | More | | Minocycline | hsa04940 | Type I diabetes mellitus | 2.91E-03 | 3 | P10747, P13765, P01375 | CD28, HLA-DOB, TNF | More | | Minocycline | hsa04970 | Salivary secretion | 2.09E-04 | 8 | P07550, Q08828, P51828, P22694, Q14643, P0DP24, P0DP23, P49913 | ADRB2, ADCY1, ADCY7, PRKACB, ITPR1, CALM2, CALM1, CAMP | More | | Minocycline | hsa04971 | Gastric acid secretion | 4.55E-06 | 6 | Q08828, P51828, P15311, P0DP24, P0DP23, Q13557 | ADCY1, ADCY7, VIL2, CALM2, CALM1, CAMK2D | More | | Minocycline | hsa04976 | Bile secretion | 1.64E-03 | 4 | Q08828, P51828, Q14032, Q9BY07 | ADCY1, ADCY7, BAAT, SLC4A5 | More | | Minocycline | hsa05010 | Alzheimer disease | 6.54E-05 | 14 | O15239, O95298, P12074, Q00535, O75460, P0DP24, P0DP23, P01584, P18848, O15169, P31751, P05141, P28070, P43686 | NDUFA1, NDUFC2, COX6A1, CDK5, ERN1, CALM2, CALM1, IL1B, ATF4, AXIN1, AKT2, SLC25A5, PSMB4, PSMC4 | More | | Minocycline | hsa05012 | Parkinson disease | 6.66E-04 | 10 | O15239, P13073, P12074, P05141, O75460, P18848, P28070, P43686, P0DP24, Q13557 | NDUFA1, COX4I1, COX6A1, SLC25A5, ERN1, ATF4, PSMB4, PSMC4, CALM2, CAMK2D | More | | Minocycline | hsa05016 | Huntington disease | 2.83E-04 | 11 | O15239, O95298, P13073, P12074, P24928, P30876, P62487, P05141, O75460, P28070, P43686 | NDUFA1, NDUFC2, COX4I1, COX6A1, POLR2A, POLR2B, POLR2G, SLC25A5, ERN1, PSMB4, PSMC4 | More | | Minocycline | hsa05017 | Spinocerebellar ataxia | 3.94E-02 | 4 | O75460, P31751, P28070, P05141 | ERN1, AKT2, PSMB4, SLC25A5 | More | | Minocycline | hsa05020 | Prion disease | 5.42E-04 | 12 | P13591, P01584, P46531, P11142, O15239, P13073, P12074, P18848, P05141, P28070, P43686, Q99941 | NCAM1, IL1B, NOTCH1, HSPA8, NDUFA1, COX4I1, COX6A1, ATF4, SLC25A5, PSMB4, PSMC4, CREBL1 | More | | Minocycline | hsa05022 | Pathways of neurodegeneration - multiple diseases | 1.48E-05 | 16 | O15239, O95298, P13073, P12074, Q8TEV9, O75460, P18848, P05141, Q00535, O15169, P01584, P0DP24, P0DP23, Q13557, P28070, P43686 | NDUFA1, NDUFC2, COX4I1, COX6A1, SMCR8, ERN1, ATF4, SLC25A5, CDK5, AXIN1, IL1B, CALM2, CALM1, CAMK2D, PSMB4, PSMC4 | More | | Minocycline | hsa05030 | Cocaine addiction | 3.54E-02 | 3 | Q00535, Q99941, P18848 | CDK5, CREBL1, ATF4 | More | | Minocycline | hsa05031 | Amphetamine addiction | 7.61E-03 | 4 | P0DP24, Q13557, Q99941, P18848 | CALM2, CAMK2D, CREBL1, ATF4 | More | | Minocycline | hsa05032 | Morphine addiction | 1.27E-02 | 4 | P63218, P50151, Q07343, P43250 | GNG5, GNG10, PDE4B, GRK6 | More | | Minocycline | hsa05034 | Alcoholism | 2.89E-03 | 4 | Q93077, P62807, O60814, P68431 | HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Minocycline | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 2.45E-02 | 4 | Q16539, P09341, P25024, P25025 | MAPK14, CXCL1, CXCR1, CXCR2 | More | | Minocycline | hsa05130 | Pathogenic Escherichia coli infection | 7.39E-03 | 4 | Q14247, P56750, O00501, P25116 | CTTN, CLDN17, CLDN5, F2R | More | | Minocycline | hsa05133 | Pertussis | 2.41E-02 | 2 | P09871, Q02556 | C1S, IRF8 | More | | Minocycline | hsa05134 | Legionellosis | 1.28E-02 | 3 | P01584, P68104, P11142 | IL1B, EEF1A1, HSPA8 | More | | Minocycline | hsa05140 | Leishmaniasis | 1.04E-06 | 12 | P13612, O75015, P14598, P13765, O60603, P25963, P01375, P29350, P49006, Q16539, P51617, Q15080 | ITGA4, FCGR3B, NCF1, HLA-DOB, TLR2, NFKBIA, TNF, PTPN6, MARCKSL1, MAPK14, IRAK1, NCF4 | More | | Minocycline | hsa05143 | African trypanosomiasis | 3.19E-02 | 2 | P69905, P68871 | HBA2, HBB | More | | Minocycline | hsa05144 | Malaria | 4.92E-02 | 4 | O60603, P01375, P35443, P26718 | TLR2, TNF, THBS4, KLRK1 | More | | Minocycline | hsa05146 | Amoebiasis | 4.21E-06 | 10 | P09341, P14778, P27930, P01375, O60603, P42338, P05089, P22694, P12814, P08311 | CXCL1, IL1R1, IL1R2, TNF, TLR2, PIK3CB, ARG1, PRKACB, ACTN1, CTSG | More | | Minocycline | hsa05150 | Staphylococcus aureus infection | 1.65E-02 | 6 | P21730, P21462, O75015, P13765, Q16581, P49913 | C5AR1, FPR1, FCGR3B, HLA-DOB, C3AR1, CAMP | More | | Minocycline | hsa05152 | Tuberculosis | 8.54E-03 | 9 | O75015, P48382, O60603, P01375, P10415, P13765, P49913, Q9UDY8, P51617 | FCGR3B, RFX5, TLR2, TNF, BCL2, HLA-DOB, CAMP, MALT1, IRAK1 | More | | Minocycline | hsa05162 | Measles | 4.02E-02 | 3 | P11142, P01584, Q9NP90 | HSPA8, IL1B, RAB9B | More | | Minocycline | hsa05163 | Human cytomegalovirus infection | 4.76E-09 | 20 | P31751, P01375, Q14643, P0DP24, P0DP23, Q8NHW4, Q08828, P51828, P23458, P49841, P14778, P01584, P61073, Q13651, P25025, Q16539, Q99941, P18848, P04637, O00463 | AKT2, TNF, ITPR1, CALM2, CALM1, CCL4L2, ADCY1, ADCY7, JAK1, GSK3B, IL1R1, IL1B, CXCR4, IL10RA, CXCR2, MAPK14, CREBL1, ATF4, TP53, TRAF5 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P31751 | AKT2 | RAC-beta serine/threonine-protein kinase | 0.726 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P01375 | TNF | Tumor necrosis factor | 0.732 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.728 | P01584 | IL1B | Interleukin-1 beta | P0DP24 | CALM2 | Calmodulin-2 | 0.72 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P0DP23 | CALM1 | Calmodulin-1 | 0.857 | P01584 | IL1B | Interleukin-1 beta | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.766 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.756 | P01584 | IL1B | Interleukin-1 beta | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.766 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.756 | P01584 | IL1B | Interleukin-1 beta | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.75 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.796 | P01584 | IL1B | Interleukin-1 beta | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.815 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.726 | P01584 | IL1B | Interleukin-1 beta | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.799 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.842 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.78 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.778 | P01584 | IL1B | Interleukin-1 beta | P01584 | IL1B | Interleukin-1 beta | 1 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P01584 | IL1B | Interleukin-1 beta | 0.735 | P01584 | IL1B | Interleukin-1 beta | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | 0.825 | P01584 | IL1B | Interleukin-1 beta | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | 0.82 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | 0.786 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.889 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.861 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.78 | P01584 | IL1B | Interleukin-1 beta | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.704 | P01584 | IL1B | Interleukin-1 beta | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.749 | Q00535 | CDK5 | Cyclin-dependent-like kinase 5 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.748 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P04637 | TP53 | Cellular tumor antigen p53 | -0.823 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.734 |
| Minocycline | hsa05164 | Influenza A | 4.49E-02 | 5 | P31751, P01584, P23458, P05141, Q9UBU9 | AKT2, IL1B, JAK1, SLC25A5, NXF1 | More | | Minocycline | hsa05166 | Human T-cell leukemia virus 1 infection | 3.90E-02 | 7 | P23458, P05141, P62826, Q08828, P51828, P18848, P31751 | JAK1, SLC25A5, RAN, ADCY1, ADCY7, ATF4, AKT2 | More | | Minocycline | hsa05171 | Coronavirus disease - COVID-19 | 9.72E-03 | 7 | P01584, P62753, P25398, P36578, P32969, P18077, P62829 | IL1B, RPS6, RPS12, RPL4, RPL9, RPL35A, RPL23 | More | | Minocycline | hsa05200 | Pathways in cancer | 9.46E-03 | 17 | Q13751, P42338, P08238, P19174, P43246, P84022, Q13485, Q13547, P30281, P49767, P43657, P63218, P50151, Q14344, Q7LDG7, O75293, P14784 | LAMB3, PIK3CB, HSP90AB1, PLCG1, MSH2, SMAD3, SMAD4, HDAC1, CCND3, VEGFC, P2RY5, GNG5, GNG10, GNA13, RASGRP2, GADD45B, IL2RB | More | | Minocycline | hsa05202 | Transcriptional misregulation in cancer | 2.97E-04 | 17 | Q12778, Q15532, P14780, P27930, P14923, Q15744, Q16548, Q13489, Q13077, P35226, P05164, P12838, P08246, Q9C0K0, P41182, P12980, P24522 | FOXO1, SS18, MMP9, IL1R2, JUP, CEBPE, BCL2A1, BIRC3, TRAF1, BMI1, MPO, DEFA4, ELA2, BCL11B, BCL6, LYL1, GADD45A | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P22894 | MMP8 | Neutrophil collagenase | Q12778 | FOXO1 | Forkhead box protein O1 | -0.72 | P22894 | MMP8 | Neutrophil collagenase | Q15532 | SS18 | Protein SSXT | -0.867 | P14780 | MMP9 | Matrix metalloproteinase-9 | P14780 | MMP9 | Matrix metalloproteinase-9 | 1 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.9 | P22894 | MMP8 | Neutrophil collagenase | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.882 | P14780 | MMP9 | Matrix metalloproteinase-9 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.851 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.721 | P22894 | MMP8 | Neutrophil collagenase | P14923 | JUP | Junction plakoglobin | -0.809 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | 0.7 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | 0.772 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.921 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.776 | P22894 | MMP8 | Neutrophil collagenase | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.843 | P22894 | MMP8 | Neutrophil collagenase | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.765 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.758 | P22894 | MMP8 | Neutrophil collagenase | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.806 | P14780 | MMP9 | Matrix metalloproteinase-9 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.89 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.716 | P22894 | MMP8 | Neutrophil collagenase | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.821 | P14780 | MMP9 | Matrix metalloproteinase-9 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.89 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.716 | P22894 | MMP8 | Neutrophil collagenase | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.821 | P14780 | MMP9 | Matrix metalloproteinase-9 | P05164 | MPO | Myeloperoxidase | 0.812 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P05164 | MPO | Myeloperoxidase | 0.909 | P22894 | MMP8 | Neutrophil collagenase | P05164 | MPO | Myeloperoxidase | 0.905 | P14780 | MMP9 | Matrix metalloproteinase-9 | P12838 | DEFA4 | Neutrophil defensin 4 | 0.858 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P12838 | DEFA4 | Neutrophil defensin 4 | 0.882 | P14780 | MMP9 | Matrix metalloproteinase-9 | P08246 | ELA2 | Neutrophil elastase | 0.859 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P08246 | ELA2 | Neutrophil elastase | 0.889 | P22894 | MMP8 | Neutrophil collagenase | P08246 | ELA2 | Neutrophil elastase | 0.985 | P14780 | MMP9 | Matrix metalloproteinase-9 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.752 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.85 | P22894 | MMP8 | Neutrophil collagenase | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.778 | P14780 | MMP9 | Matrix metalloproteinase-9 | P41182 | BCL6 | B-cell lymphoma 6 protein | 0.812 | P14780 | MMP9 | Matrix metalloproteinase-9 | P12980 | LYL1 | Protein lyl-1 | 0.716 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P12980 | LYL1 | Protein lyl-1 | 0.702 | P14780 | MMP9 | Matrix metalloproteinase-9 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.765 | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.859 | P22894 | MMP8 | Neutrophil collagenase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.766 |
| Minocycline | hsa05203 | Viral carcinogenesis | 4.85E-02 | 3 | Q15283, P62807, O60814 | RASA2, HIST1H2BC, H2BC12 | More | | Minocycline | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Minocycline | hsa05212 | Pancreatic cancer | 2.74E-03 | 7 | P42338, P31751, Q15311, P23458, P84022, Q13485, O75293 | PIK3CB, AKT2, RALBP1, JAK1, SMAD3, SMAD4, GADD45B | More | | Minocycline | hsa05219 | Bladder cancer | 4.07E-02 | 2 | P14780, P04637 | MMP9, TP53 | More | | Minocycline | hsa05220 | Chronic myeloid leukemia | 2.16E-02 | 5 | Q13547, Q13485, P84022, P42338, O75293 | HDAC1, SMAD4, SMAD3, PIK3CB, GADD45B | More | | Minocycline | hsa05224 | Breast cancer | 4.75E-02 | 4 | P49841, Q92837, P04637, P24522 | GSK3B, FRAT1, TP53, GADD45A | More | | Minocycline | hsa05231 | Choline metabolism in cancer | 3.38E-02 | 3 | P31751, Q16760, O14986 | AKT2, DGKD, PIP5K1B | More | | Minocycline | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 1.97E-03 | 10 | P42338, O95267, P07766, P20963, P09693, P06239, O60603, Q04759, Q16539, P01730 | PIK3CB, RASGRP1, CD3E, CD247, CD3G, LCK, TLR2, PRKCQ, MAPK14, CD4 | More | | Minocycline | hsa05310 | Asthma | 2.84E-05 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Minocycline | hsa05321 | Inflammatory bowel disease | 3.13E-07 | 6 | O60603, P01375, P13765, Q14765, Q9UL17, P23771 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3 | More | | Minocycline | hsa05322 | Systemic lupus erythematosus | 1.24E-04 | 13 | O75015, P08246, P08311, P09871, P01375, P10747, P13765, Q6FI13, Q93077, P62807, O60814, P68431, P05455 | FCGR3B, ELA2, CTSG, C1S, TNF, CD28, HLA-DOB, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, SSB | More | | Minocycline | hsa05323 | Rheumatoid arthritis | 1.58E-02 | 5 | P01375, P13765, P10747, P09341, O60603 | TNF, HLA-DOB, CD28, CXCL1, TLR2 | More | | Minocycline | hsa05332 | Graft-versus-host disease | 1.09E-05 | 5 | P13765, P10747, P01375, P26715, Q13241 | HLA-DOB, CD28, TNF, KLRC1, KLRD1 | More | | Minocycline | hsa05415 | Diabetic cardiomyopathy | 2.87E-02 | 4 | P05141, O15239, P13073, Q13557 | SLC25A5, NDUFA1, COX4I1, CAMK2D | More | | Minocycline | hsa05418 | Fluid shear stress and atherosclerosis | 1.26E-04 | 8 | Q16539, Q14145, P10599, P14780, P01375, P04637, P14778, P27930 | MAPK14, KEAP1, TXN, MMP9, TNF, TP53, IL1R1, IL1R2 | More | | |